Table 1.
Demographic profile of study cohort.
| Patient characteristics | N (%), N = 33 |
|---|---|
| Median age (Range) | 62 years (17−80 years) |
| Elderly (≥ 60 years) | 20 (60.6%) |
| Child (17 years) | 1(3%) |
| Gender | |
| Male | 23 (69.7%) |
| Female | 10 (30.3%) |
| Comorbidities | |
| Median number of comorbidities (range) | 1 (0–5) |
| Hypertension | 14 (42.4%) |
| Diabetes Mellitus | 9 (27.3%) |
| Ischemic heart disease | 2 (6.1%) |
| Hypothyroidism | 3 (9.1%) |
| Chronic Liver disease | 1 (3.0%) |
| Pulmonary tuberculosis | 1 (3.0%) |
| Others | 4 (12.1%) |
| Number of comorbidities | |
| 0 | 16 (48.5%) |
| 1 | 7 (21.2%) |
| 2 | 6 (18.25%) |
| 3 | 2 (6.1%) |
| 5 | 2 (6.1%) |
| Diagnosis | |
| Acute leukemia | 4 (12.1%) |
| Acute myeloid leukemia | 3 (9.1%) |
| Acute lymphoblastic leukemia | 1 (3%) |
| Myelodysplastic syndrome-Excess Blasts | 2 (6%) |
| Chronic myeloid leukemia | 2 (6%) |
| Non-hodgkin lymphoma | 18 (54.5%) |
| Chronic lymphocytic leukemia | 7 (21.2%) |
| Diffuse large B-cell lymphoma | 8 (24.2%) |
| Mantle cell lymphoma | 1(3%) |
| Hairy cell leukemia | 1(3%) |
| Angioimmunoblastic T-cell lymphoma | 1(3%) |
| Multiple myeloma | 7 (21.2%) |
| Status of disease | |
| Newly diagnosed | 8 (24.2%) |
| Yet to be assessed (on treatment before assessment) | 1 (3%) |
| Remission (Complete, very good or partial) | 9(27.3%) |
| Stable disease (Observation) | 5 (15.15%) |
| Relapse/Refractory | 10 (30.3%) |
| Active treatment | 24 (72.7%) |
| Not started therapy/ follow up/observation | 9 (27.3%) |
| Chemotherapy (C) | 5 (15.2%) |
| Immunotherapy (I) | 2 (6.1%) |
| Oral targeted (O) | 4 (12.1%) |
| C + I | 6 (18.2%) |
| C + O / C + I+O | 7 (21.2%) |